D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 79 Citations 17,261 140 World Ranking 749 National Ranking 362

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Microbiology
  • Internal medicine

The scientist’s investigation covers issues in Microbiology, Fluconazole, Candida albicans, Corpus albicans and Voriconazole. Microbiology and Mycosis are frequently intertwined in his study. Richard J. Hollis combines subjects such as Echinocandin and Caspofungin with his study of Mycosis.

His research in Fluconazole intersects with topics in Broth microdilution and Candida glabrata. His research on Candida albicans often connects related areas such as Itraconazole. His study looks at the relationship between Corpus albicans and fields such as Drug resistance, as well as how they intersect with chemical problems.

His most cited work include:

  • International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. (479 citations)
  • Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998 (363 citations)
  • Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. (342 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Microbiology, Fluconazole, Broth microdilution, Typing and Voriconazole. His work on Microbiology is being expanded to include thematically relevant topics such as Pulsed-field gel electrophoresis. The study incorporates disciplines such as Amphotericin B, Minimum inhibitory concentration, Mycosis and Cryptococcus neoformans in addition to Fluconazole.

His work deals with themes such as Caspofungin, Agar, Etest, Candida spp and Drug resistance, which intersect with Broth microdilution. His Typing study combines topics in areas such as Infection control, Restriction enzyme, Outbreak, Staphylococcus aureus and Restriction fragment. As a part of the same scientific study, Richard J. Hollis usually deals with the Voriconazole, concentrating on Aspergillus and frequently concerns with Aspergillus fumigatus and Aspergillus terreus.

He most often published in these fields:

  • Microbiology (92.96%)
  • Fluconazole (38.03%)
  • Broth microdilution (24.65%)

What were the highlights of his more recent work (between 2003-2021)?

  • Microbiology (92.96%)
  • Broth microdilution (24.65%)
  • Fluconazole (38.03%)

In recent papers he was focusing on the following fields of study:

Richard J. Hollis focuses on Microbiology, Broth microdilution, Fluconazole, Voriconazole and Posaconazole. His study looks at the relationship between Microbiology and topics such as Mycosis, which overlap with Surrogate endpoint. His study in Broth microdilution is interdisciplinary in nature, drawing from both Agar, Drug resistance and Etest.

His Fluconazole study incorporates themes from Amphotericin B, Candida glabrata and Cryptococcus neoformans. He combines subjects such as Itraconazole, Potency and Aspergillus with his study of Voriconazole. As part of the same scientific family, Richard J. Hollis usually focuses on Caspofungin, concentrating on Micafungin and intersecting with Echinocandin.

Between 2003 and 2021, his most popular works were:

  • In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance (340 citations)
  • Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases (332 citations)
  • In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program (211 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Internal medicine
  • Microbiology

His primary areas of investigation include Microbiology, Fluconazole, Fungi imperfecti, Caspofungin and Broth microdilution. Microbiology connects with themes related to Mycosis in his study. His work carried out in the field of Fluconazole brings together such families of science as Candida parapsilosis, Amphotericin B and Candida glabrata.

His research investigates the connection between Caspofungin and topics such as Drug resistance that intersect with problems in Patient age. Richard J. Hollis works mostly in the field of Broth microdilution, limiting it down to concerns involving Cryptococcus neoformans and, occasionally, Potency and Cryptococcosis. His Voriconazole study integrates concerns from other disciplines, such as Aspergillus fumigatus, Itraconazole, Cross-resistance and Aspergillus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

M. A. Pfaller;D. J. Diekema;R. N. Jones;H. S. Sader.
Journal of Clinical Microbiology (2001)

758 Citations

Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

Sandra S. Richter;Rudolph P. Galask;Shawn A. Messer;Richard J. Hollis.
Journal of Clinical Microbiology (2005)

671 Citations

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.

M. A. Pfaller;S. A. Messer;R. J. Hollis;R. N. Jones.
Antimicrobial Agents and Chemotherapy (2002)

536 Citations

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

Pfaller;R N Jones;G V Doern;H S Sader.
Antimicrobial Agents and Chemotherapy (2000)

494 Citations

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

M. A. Pfaller;L. Boyken;R. J. Hollis;J. Kroeger.
Journal of Clinical Microbiology (2008)

478 Citations

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

D. J. Diekema;S. A. Messer;R. J. Hollis;R. N. Jones.
Journal of Clinical Microbiology (2003)

458 Citations

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment

David R. Reagan;Bradley N. Doebbeling;Michael A. Pfaller;Carol T. Sheetz.
Annals of Internal Medicine (1991)

439 Citations

Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000

M. A. Pfaller;D. J. Diekema;R. N. Jones;S. A. Messer.
Journal of Clinical Microbiology (2002)

426 Citations

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program

M. A. Pfaller;R. N. Jones;G. V. Doern;H. S. Sader.
Journal of Clinical Microbiology (1998)

412 Citations

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

M.A Pfaller;R.N Jones;G.V Doern;A.C Fluit.
Diagnostic Microbiology and Infectious Disease (1999)

384 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Richard J. Hollis

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 174

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 113

Daniel J. Diekema

Daniel J. Diekema

University of Iowa Hospitals and Clinics

Publications: 73

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 67

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 65

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 56

Arnaldo Lopes Colombo

Arnaldo Lopes Colombo

Federal University of Sao Paulo

Publications: 52

Shawn A. Messer

Shawn A. Messer

JMI Laboratories

Publications: 52

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 50

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 48

Ana Espinel-Ingroff

Ana Espinel-Ingroff

Virginia Commonwealth University Medical Center

Publications: 45

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 44

Jack D. Sobel

Jack D. Sobel

Wayne State University

Publications: 43

John H. Rex

John H. Rex

The University of Texas Health Science Center at Houston

Publications: 42

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 42

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 41

Trending Scientists

Youn Sang Kim

Youn Sang Kim

Seoul National University

Vincent L. Pecoraro

Vincent L. Pecoraro

University of Michigan–Ann Arbor

David E. Bergbreiter

David E. Bergbreiter

Texas A&M University

Stan Veprek

Stan Veprek

Technical University of Munich

Lincoln J. Lauhon

Lincoln J. Lauhon

Northwestern University

Ilias Belharouak

Ilias Belharouak

Oak Ridge National Laboratory

Chris Huw John Davies

Chris Huw John Davies

Monash University

Kevin S. Gould

Kevin S. Gould

Victoria University of Wellington

Carolina Barillas-Mury

Carolina Barillas-Mury

National Institutes of Health

Laura Senovilla

Laura Senovilla

University of Valladolid

Peilin Jia

Peilin Jia

The University of Texas Health Science Center at Houston

Arnold R. Kriegstein

Arnold R. Kriegstein

University of California, San Francisco

Miroslaw K. Gorny

Miroslaw K. Gorny

New York University

Scott A. Myers

Scott A. Myers

West Virginia University

Matthew R. Reynolds

Matthew R. Reynolds

Tufts University

Kevin Schawinski

Kevin Schawinski

ETH Zurich

Something went wrong. Please try again later.